Davis John E, Senior VP of Global Sales, has demonstrated a clear selling bias in his trading activity involving AORT (Artivion, Inc.), with no recent purchases and 17 sales recorded since March 2024. His transactions total $3.23 million in sales against $1.23 million in buys across 36 filings, reflecting a net reduction in holdings. The most recent sales occurred on March 2-3, 2026, totaling $278,609.14, including a $172,747.82 disposition on March 3. Prior to that, a cluster of sales in November 2025—amounting to $925,918.33 over four transactions—stood out as the most concentrated period of divestment. Earlier activity included a $471,755.75 sale in August 2025 and a $356,548.75 transaction in March 2025, often accompanied by smaller, incremental disposals. The pattern suggests a steady unwinding of positions rather than abrupt liquidation, with multiple sales occurring within short timeframes. Award-related transactions (coded "M") in November 2025 and August 2025 accounted for $663,195.42 in value, indicating that some sales were tied to equity compensation. While Davis has maintained exclusive focus on AORT, the absence of recent buys and the persistence of sales over two years point to a deliberate shift away from accumulating shares in the company.
AI-assisted summary